Related content

Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles

By Peñarrubia J  

Human Reproduction, Vol. 13, Iss. 12, 1998-12 ,pp. : 3315-3318

Oxford University Press

Access to resources Recommend Favorite

Low-dose human chorionic gonadotropin during the proliferative phase may adversely affect endometrial receptivity in oocyte recipients

By Prapas Nikos   Tavaniotou Asimina   Panagiotidis Yannis   Prapa Stella   Kasapi Evangelia   Goudakou Maria   Papatheodorou Achilleas   Prapas Yannis  

Gynecological Endocrinology, Vol. 25, Iss. 1, 2009-06 ,pp. : 53-59

Informa Healthcare

Access to resources Recommend Favorite

In vitro activity of human chorionic gonadotropin (hCG) on myometrium contractility

By Angioni Stefano   Spedicato Massimo   Rizzo Annalisa   Cosola Claudia   Mutinati Maddalena   Minoia Giuseppe   Sciorsci Rafaele L.  

Gynecological Endocrinology, Vol. 27, Iss. 3, 2011-03 ,pp. : 180-184

Informa Healthcare

Access to resources Recommend Favorite

Intrauterine insemination with recombinant or urinary human chorionic gonadotropin: A prospective randomized trial

By Lorusso Filomenamila   Palmisano Marcella   Serrati Giuseppe   Bassi Emma   Lamanna Giuseppina   Vacca Margherita   Depalo Raffaella  

Gynecological Endocrinology, Vol. 24, Iss. 11, 2008-01 ,pp. : 644-648

Informa Healthcare

Access to resources Recommend Favorite

Time-dependent action of DDT (1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane) and its metabolite DDE (1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene) on human chorionic gonadotropin and progesterone secretion

By Wojtowicz Anna   Milewicz Tomasz   Gregoraszczuk Ewa Ł.  

Gynecological Endocrinology, Vol. 24, Iss. 1, 2007-10 ,pp. : 54-58

Informa Healthcare

Access to resources Recommend Favorite